将医疗器械创新转化为市场 - - 乌干达的观点
Brian Matovu1, Jackline Winfred Baluka1, Mercy Takuwa1
1Biomedical Engineering Unit, Department of Physiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
BMC research notes
|October 9, 2023
概括
医疗器械创新在低收入和中等收入国家 (LMICs) 面临重大障碍. 这项研究确定了乌干达的关键瓶,突出了改善医疗保健技术翻译的合作努力的必要性.
科学领域:
- 生物医学工程 生物医学工程
- 医疗保健服务研究 医疗服务研究
- 创新管理 创新管理
背景情况:
- 在高收入国家 (HIC) 和低收入和中等收入国家 (LMIC) 之间,医疗器械创新转化存在差异.
- 虽然HIC医疗技术面临市场准入挑战,但LMIC创新途径的理解较少.
- 撒哈拉以南非洲在医疗器械开发和进入市场方面面临着独特的挑战.
研究的目的:
- 确定和绘制乌干达医疗器械创新过程中的当前瓶,一个LMIC.
- 了解东非背景下医疗器械创新者面临的具体挑战.
- 为改善资源有限的环境中医疗保健技术翻译提供见解.
主要方法:
- 通过使用数字问卷进行了横截面调查.
- 该研究针对乌干达的医疗器械创新者和相关利益相关者.
- 从21名受访者收集数据,其中大多数是创新者.
主要成果:
- 只有一个被调查的创新者完成了临床验证的所有阶段.
- 很少有创新者成立公司或获得知识产权.
- 受访者表示在整个创新管道中存在多个多维挑战.
结论:
- 乌干达的医疗器械创新面临着重大的翻译挑战.
- 跨学科的合作对于加速医疗器械创新过程在LMICs至关重要.
- 解决多维瓶对于改善资源有限的环境中的医疗技术交付至关重要.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.7K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.7K
Microorganisms in Medicine and Therapeutics
36
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
36


